The forecast for breast cancer screening coverage in Norway indicates that the value is expected to remain relatively stable over the next five years. The coverage in 2024 is forecasted to be 71.6%, which would remain constant until 2026 before experiencing a slight decline to 71.5% in 2027 and 2028. Comparatively, in 2023, the actual coverage stood at 71.6%, showing minimal year-on-year variation. Over the period from 2023 to 2028, the Compound Annual Growth Rate (CAGR) suggests a negligible average annual decrease.
Future trends to watch for in breast cancer screening coverage in Norway include the potential impact of advancements in medical technology and diagnostics, changes in public health policies, and the implementation of more widespread awareness campaigns. Additionally, monitoring the demographic shifts and healthcare resource allocation will be key in understanding how these factors could affect future screening rates.